Procaps Group SA USD0.01

Sell:$1.12Buy:$1.12No change

Prices delayed by at least 15 minutes
Sell:$1.12
Buy:$1.12
Change:No change
Prices delayed by at least 15 minutes
Sell:$1.12
Buy:$1.12
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Procaps Group SA is a Luxembourg-based healthcare and pharmaceutical company. The Company develops, manufactures and sells prescription drugs and products that are differentiated by their combinations and pharmaceutical forms, as well as nutritional supplements which include omega 3 fish oils and high-potency clinical compounds. It operates its business through 5 units which are Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics provides diabetes solutions. Farma procaps formulates, manufactures and markets branded prescription drugs in Latin America. Softi Gel provides contract drug development and manufacturing services to third party pharmaceutical companies. Vital Care develops, manufactures and markets consumer healthcare products. Clinical Specialties develops, manufactures and markets complex drugs.

Key people

Alejandro Kostia Nicolas Weinstein Crenovich
Executive Chairman of the Board
Camilo Camacho
President
Jose Antonio Vieira
Chief Executive Officer
Melissa Angelini
Interim Vice President - Finance
Mauricio Castaneda Caballero
Vice President - Human Resources
Marcela Carvajalino Pagano
Vice President - Corporate and Legal Affairs
Grethel Moreno Romero
Vice President - Audit and Internal Controls
Luis Alberto Palacios Aragon
Vice President - International Marketing and R&D
Patricio Vargas Munoz
Chief Optimization and Rationalization Officer
Ernesto Carrizosa
Director
Jose Guillermo Frugone Domke
Director
Jose Minski
Director
Nicolas Francisco Weinstein Manieu
Director
Alberto Eguiguren Correa
Independent Director
Click to see more

Key facts

  • EPIC
    PROCF
  • Location
    Luxembourg
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    LU2376511205
  • Market cap
    $2.97bn
  • Employees
    4,900
  • Shares in issue
    112.82m
  • Exchange
    Over The Counter
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.